[go: up one dir, main page]

MY197131A - Fast dissolving solid dosage form - Google Patents

Fast dissolving solid dosage form

Info

Publication number
MY197131A
MY197131A MYPI2014700634A MYPI2014700634A MY197131A MY 197131 A MY197131 A MY 197131A MY PI2014700634 A MYPI2014700634 A MY PI2014700634A MY PI2014700634 A MYPI2014700634 A MY PI2014700634A MY 197131 A MY197131 A MY 197131A
Authority
MY
Malaysia
Prior art keywords
dosage form
solid dosage
fast dissolving
dissolving solid
active material
Prior art date
Application number
MYPI2014700634A
Inventor
Lee Yip Hang Eddy
Lim Chin Beng Stephen
Bruce Sunderland Vivian
Original Assignee
Ix Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ix Biopharma Ltd filed Critical Ix Biopharma Ltd
Priority to MYPI2014700634A priority Critical patent/MY197131A/en
Publication of MY197131A publication Critical patent/MY197131A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

There is provided a fast dissolving solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit comprising the same are also provided.
MYPI2014700634A 2010-10-26 2010-10-26 Fast dissolving solid dosage form MY197131A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2014700634A MY197131A (en) 2010-10-26 2010-10-26 Fast dissolving solid dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2014700634A MY197131A (en) 2010-10-26 2010-10-26 Fast dissolving solid dosage form

Publications (1)

Publication Number Publication Date
MY197131A true MY197131A (en) 2023-05-26

Family

ID=87654765

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014700634A MY197131A (en) 2010-10-26 2010-10-26 Fast dissolving solid dosage form

Country Status (1)

Country Link
MY (1) MY197131A (en)

Similar Documents

Publication Publication Date Title
MY150626A (en) Fast dissolving solid dosage form
MY191875A (en) Solid dosage form
MX2015017036A (en) Method for producing renal precursor cells, and drug containing renal precursor cells.
EP2279227A4 (en) Anionic latex as a carrier for active ingredients and methods for making and using the same
CR10349A (en) FAST LIBERATION PARACETAMOL TABLETS
MX2013008850A (en) Compositions and methods for treating cardiovascular diseases.
JO3052B1 (en) Dividable galenical form allowing modified release of the active ingredient
PH12015500727A1 (en) Pharmaceutical compositions
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
MX350447B (en) A fast dissolving pharmaceutical composition.
PH12012501258A1 (en) Processes for the manufacture of a pharmaceutically active agent
MX354691B (en) A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]th iophene-2-carboxamide hydrochloride monohydrate.
PL2217219T3 (en) A sublingual effervescent tablet of progesterone associated with cyclodextrin
PH12014502834B1 (en) Pharmaceutical form for extended release of active substances
MY162688A (en) Oral care compositions
MX2011006721A (en) Pharmaceutical formulation of nanonised fenofibrate.
MY197131A (en) Fast dissolving solid dosage form
WO2011062936A3 (en) Self-assembled toroidal-spiral particles and manufacture and uses thereof
MX2013000003A (en) Intravaginal devices comprising anticholinergic agents, and methods of making thereof.
TH134919A (en) Quick-dissolving solid dosage form
TW200833375A (en) Pharmaceutical compositions
GEP20094712B (en) Means for treatment of diabetes mellitis
CL2010001172A1 (en) Solid thermostable pharmaceutical composition comprising an active pharmaceutical ingredient of poor permeability and at least one permeability enhancing substance, incorporated in a thermostable form in a water soluble matrix of a water soluble carrier; and a process to prepare it.
UA58396U (en) Method for preventing impairment of liver function in patients with acute biliary pancreatitis complicated with acute hepatic failure
UA33400U (en) Pharmaceutical composition in the form of tablets with antiallergic action